Tang Capital Management’s TransCode Therapeutics RNAZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	-$42.2K	–	131
2023 Q3	$42.2K	Buy	+2	New	+$42.2K	0.01%	106